Perhaps the most extensive of these would be the TREAT-NMD DMD Global Registry [11] and the Leiden Open Variation Database (LOVD) [12,13], each having data from more than 7000 dystrophinopathy patients across the world. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.